Pharmaceuticals, Biotechnology and Life Sciences
SAN FRANCISCO–(BUSINESS WIRE)–Unlearn®, a company at the forefront of AI in medicine, today announced the newest version of its TwinRCT™…
CEL-4000 may deliver safe and effective therapy for RA by rebalancing the inflammatory response, without weakening important immune defense mechanisms,…
– Application based on integrated global data dossier completed for Lerodalcibep by LIB – Hasten to begin bridging studies to…
CHICAGO–(BUSINESS WIRE)–Gravis is thrilled to launch its new name and brand identity following the successful combination of six leading players…
Results from multiple Phase 3 trials of V116 and a real-world evidence study of pneumococcal serotypes presented at the 13th…
Gunda Georg delivered phase 1a study details at the American Chemical Society Meeting SAN FRANCISCO–(BUSINESS WIRE)–YourChoice Therapeutics, a San Francisco…
SOMERSET, N.J.–(BUSINESS WIRE)–Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today released its inaugural Environmental,…
OASIS 3 study provides additional supporting efficacy data as well as long-term safety data of elinzanetant, complementing positive topline results…
HOUSTON–(BUSINESS WIRE)–Coya Therapeutics, Inc. (Nasdaq: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance regulatory…
Favorable Safety and Tolerability also Observed HOUSTON–(BUSINESS WIRE)–$KRBP #CART—Kiromic BioPharma, Inc. (OTCQB: KRBP) (“Kiromic” or the “Company”) reports early efficacy…